Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Acquisition

6 Jul 2007 07:01

Cello Group plc06 July 2007 6 July 2007 Cello Group plc Cello expands financial services capability with the acquisition of cchm:ping Cello Group plc ("Cello", AIM: CLL), the market research and consulting group,has acquired a controlling interest in Hill Murray Group Limited, the holdingcompany of cchm:ping Limited ("cchm:ping"), a specialist financial servicesmarketing agency with options to acquire the balance of the shares. The totalmaximum consideration for the acquisition of 100% of Hill Murray Group Limitedis approximately £5.3 million in cash, loan notes and new ordinary shares. cchm:ping, which was established in 1997, has a number of blue chip financialservices clients including Aegon, Bristol & West Mortgages, Legal & General,Nationwide, Lloyds TSB & Scottish Life. Cello has acquired just over 76% of cchm:ping for an initial consideration ofapproximately £0.95 million of which £0.76 million is payable in cash and thebalance satisfied by the issue of 127,307 new ordinary shares. The remaining 24%is subject to put and call options exercisable in the period 2008 to 2011 withthe option prices being determined by the financial performance of cchm:pingduring the period to 31 December 2010. The option consideration is payable incash, loan notes and new ordinary shares with a minimum amount to be settled incash, loan notes varying from 80% for an option exercised in 2008 to 25% for anoption exercised in 2011. As part of the transaction Cello has also agreed to acquire a controllinginterest (60% on a fully diluted basis) in the issued share capital of thefinancial services consultancy, The Consultancy Practice Limited. The remainingminority interest is the subject of a put option whereby Cello can be requiredto purchase the 40% minority interest at any time in the period from March 2010to March 2013. The option consideration is payable in a mixture of cash, loannotes and new ordinary shares at Cello's discretion with a minimum loan noteconsideration of 25% for an option exercised before March 2011 and 35%thereafter. The maximum option consideration price is £1.75million and is basedon demanding performance related criteria. For the year to 30 September 2006, cchm:ping had an audited turnover of £8.0million, gross profits of £5.6million and delivered a loss before tax of £0.3million. Net assets as at 30 September 2006 were £0.7 million including cash of£0.6 million. Application has been made to the London Stock Exchange for the new shares to beadmitted to AIM and it is expected that admission will take place by 12 July2007. Kevin Steeds, Cello Chairman, said: "cchm:ping is a highly regarded specialist financial services marketing agencywith an excellent client base. As part of our Response division, based inLondon, it will complement our existing business and give us considerably moredepth in the financial services sector vertical." Enquiries: Cello GroupKevin Steeds, Executive Chairman 020 7812 8460 College HillAdrian Duffield/Ben Way 020 7457 2020 Notes to Editors (www.cellogroup.co.uk) Cello is a market research and consulting group that listed on AIM in November2004. The Group's strategy is to create value for shareholders by building a portfolioof research and consulting businesses capable of advising blue chip clientsglobally. Cello has annualised turnover in excess of £90million, gross profits of over £50million and employs approx 550 professional staff. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Sep 20167:00 amRNSInterim Results
9th Sep 20163:45 pmRNSBlock listing Interim Review
31st Aug 20162:29 pmRNSTotal Voting Rights
2nd Aug 201610:50 amRNSTotal Voting Rights
26th Jul 20167:00 amRNSPRE CLOSE TRADING STATEMENT
30th Jun 201610:19 amRNSTotal Voting Rights
20th Jun 20163:14 pmRNSDirector/PDMR Shareholding
3rd Jun 20162:42 pmRNSAdditional Listing and Total Voting Rights
31st May 20168:58 amRNSTotal Voting Rights
20th May 20162:33 pmRNSReplacement: Director/PDMR Shareholding
20th May 20161:30 pmRNSDirector/PDMR Shareholding
18th May 201612:12 pmRNSGrant of Options
16th May 20167:00 amRNSVAT Update
10th May 20163:30 pmRNSResult of AGM
10th May 20167:00 amRNSAGM Statement
29th Apr 20167:00 amRNSTotal Voting Rights
15th Apr 20165:03 pmRNSAnnual Report and notice of AGM
1st Apr 20169:02 amRNSTotal Voting Rights
23rd Mar 20164:21 pmRNSVAT Update
17th Mar 20167:00 amRNSPreliminary Results
1st Mar 201612:52 pmRNSBlocklisting Interim Review
29th Feb 201612:05 pmRNSTotal Voting Rights
29th Feb 20169:57 amRNSAdoption of Financial Reporting Standard (FRS) 101
10th Feb 20163:58 pmRNSHolding(s) in Company
29th Jan 20169:33 amRNSTotal Voting Rights
27th Jan 20167:00 amRNSPRE CLOSE TRADING STATEMENT
30th Oct 20159:25 amRNSTotal Voting Rights
8th Oct 20151:11 pmRNSAdditional Block Listing
30th Sep 20151:15 pmRNSTotal Voting Rights
28th Sep 20152:39 pmRNSHolding(s) in Company
23rd Sep 20152:20 pmRNSHolding(s) in Company
16th Sep 20154:55 pmRNSInterim Dividend Timetable
16th Sep 20157:00 amRNSInterim Results
28th Aug 201510:46 amRNSTotal Voting Rights
12th Aug 201511:57 amRNSBlocklisting Interim Review
31st Jul 201510:13 amRNSTotal Voting Rights
21st Jul 20157:00 amRNSTrading update
1st Jul 20154:20 pmRNSHolding(s) in Company
1st Jul 20151:30 pmRNSTotal Voting Rights
29th May 201511:08 amRNSTotal Voting Rights
15th May 20157:00 amRNSAdditional Listing / TVR
12th May 20151:08 pmRNSResults of Annual General Meeting
12th May 20157:00 amRNSAGM Statement
1st May 201510:43 amRNSTotal Voting Rights
20th Apr 20158:45 amRNSAnnual Report and Accounts 2014 and Notice of AGM
31st Mar 201510:17 amRNSTotal Voting Rights
19th Mar 20157:00 amRNSFinal Results
27th Feb 201511:27 amRNSTotal Voting Rights
9th Feb 20151:34 pmRNSUpdate on potential VAT assessment
2nd Feb 20158:17 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.